Migraine Therapeutics Market Report
Top key players profiled in this report: Allergan, Amirall, AstraZeneca, CoLucid Pharmaceuticals, GlaxoSmithKline, Merck, NeurAxon, NuPathe, OptiNose, Pfizer, RedHill Biopharma, Revance Therapeutics, SUDA, Teva, Vernalis, and Zogenix, among others.
has anyone read this report?
Ann: Operational Update, page-115
-
- There are more pages in this discussion • 25 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ALA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
16.5¢ |
Change
0.010(6.45%) |
Mkt cap ! $173.4M | |||
| Open | High | Low | Value | Volume |
| 16.0¢ | 16.8¢ | 15.5¢ | $942.3K | 5.824M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 317548 | 16.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.0¢ | 1378930 | 6 |
View Market Depth
| Last trade - 16.10pm 17/07/2024 (20 minute delay) ? |
| ALA (ASX) Chart |